The Werner syndrome protein is involved in RNA polymerase II transcription

Werner syndrome (WS) is a human progeroid syndrome characterized by the early onset of a large number of clinical features associated with the normal aging process. The complex molecular and cellular phenotypes of WS involve characteristic features of genomic instability and accelerated replicative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular biology of the cell 1999-08, Vol.10 (8), p.2655-2668
Hauptverfasser: Balajee, A S, Machwe, A, May, A, Gray, M D, Oshima, J, Martin, G M, Nehlin, J O, Brosh, R, Orren, D K, Bohr, V A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2668
container_issue 8
container_start_page 2655
container_title Molecular biology of the cell
container_volume 10
creator Balajee, A S
Machwe, A
May, A
Gray, M D
Oshima, J
Martin, G M
Nehlin, J O
Brosh, R
Orren, D K
Bohr, V A
description Werner syndrome (WS) is a human progeroid syndrome characterized by the early onset of a large number of clinical features associated with the normal aging process. The complex molecular and cellular phenotypes of WS involve characteristic features of genomic instability and accelerated replicative senescence. The gene involved (WRN) was recently cloned, and its gene product (WRNp) was biochemically characterized as a helicase. Helicases play important roles in a variety of DNA transactions, including DNA replication, transcription, repair, and recombination. We have assessed the role of the WRN gene in transcription by analyzing the efficiency of basal transcription in WS lymphoblastoid cell lines that carry homozygous WRN mutations. Transcription was measured in permeabilized cells by [3H]UTP incorporation and in vitro by using a plasmid template containing the RNA polymerase II (RNA pol II)-dependent adenovirus major late promoter. With both of these approaches, we find that the transcription efficiency in different WS cell lines is reduced to 40-60% of the transcription in cells from normal individuals. This defect can be complemented by the addition of normal cell extracts to the chromatin of WS cells. Addition of purified wild-type WRNp but not mutated WRNp to the in vitro transcription assay markedly stimulates RNA pol II-dependent transcription carried out by nuclear extracts. A nonhelicase domain (a direct repeat of 27 amino acids) also appears to have a role in transcription enhancement, as revealed by a yeast hybrid-protein reporter assay. This is further supported by the lack of stimulation of transcription when mutant WRNp lacking this domain was added to the in vitro assay. We have thus used several approaches to show a role for WRNp in RNA pol II transcription, possibly as a transcriptional activator. A deficit in either global or regional transcription in WS cells may be a primary molecular defect responsible for the WS clinical phenotype.
doi_str_mv 10.1091/mbc.10.8.2655
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_25497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69939566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-88b43d4e14f7a09488853d256e9b3fc5cecb974bbdebdbec97b537d241588bbe3</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxYMoWqtHr5KTt63JbrKbgJciflSKglQ8hk12aiO7yZpsC_3vTamInubBvDfz-CF0QcmEEkmvO22SmIhJXnJ-gEZUFjJjXJSHSRMuM8pzdoJOY_wkhDJWVsfohBJWlCQnI_S0WAF-h-Ag4Lh1TfAd4D74AazDNmLrNr7dQJMEfn2e4t632w5CHQHPZngItYsm2H6w3p2ho2XdRjj_mWP0dn-3uH3M5i8Ps9vpPDOsEkMmhGZFw4CyZVUTyYQQvGhyXoLUxdJwA0bLimndgG40GFlpXlRNzihPUQ3FGN3s7_Zr3UFjwKUareqD7eqwVb626v_G2ZX68BuVcyarFL_6iQf_tYY4qM5GA21bO_DrqEqZCPKyTMZsbzTBxxhg-fuCErVjrxL7nRZqxz75L__2-uPewy6-AU64glA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69939566</pqid></control><display><type>article</type><title>The Werner syndrome protein is involved in RNA polymerase II transcription</title><source>MEDLINE</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Balajee, A S ; Machwe, A ; May, A ; Gray, M D ; Oshima, J ; Martin, G M ; Nehlin, J O ; Brosh, R ; Orren, D K ; Bohr, V A</creator><contributor>Gall, Joseph</contributor><creatorcontrib>Balajee, A S ; Machwe, A ; May, A ; Gray, M D ; Oshima, J ; Martin, G M ; Nehlin, J O ; Brosh, R ; Orren, D K ; Bohr, V A ; Gall, Joseph</creatorcontrib><description>Werner syndrome (WS) is a human progeroid syndrome characterized by the early onset of a large number of clinical features associated with the normal aging process. The complex molecular and cellular phenotypes of WS involve characteristic features of genomic instability and accelerated replicative senescence. The gene involved (WRN) was recently cloned, and its gene product (WRNp) was biochemically characterized as a helicase. Helicases play important roles in a variety of DNA transactions, including DNA replication, transcription, repair, and recombination. We have assessed the role of the WRN gene in transcription by analyzing the efficiency of basal transcription in WS lymphoblastoid cell lines that carry homozygous WRN mutations. Transcription was measured in permeabilized cells by [3H]UTP incorporation and in vitro by using a plasmid template containing the RNA polymerase II (RNA pol II)-dependent adenovirus major late promoter. With both of these approaches, we find that the transcription efficiency in different WS cell lines is reduced to 40-60% of the transcription in cells from normal individuals. This defect can be complemented by the addition of normal cell extracts to the chromatin of WS cells. Addition of purified wild-type WRNp but not mutated WRNp to the in vitro transcription assay markedly stimulates RNA pol II-dependent transcription carried out by nuclear extracts. A nonhelicase domain (a direct repeat of 27 amino acids) also appears to have a role in transcription enhancement, as revealed by a yeast hybrid-protein reporter assay. This is further supported by the lack of stimulation of transcription when mutant WRNp lacking this domain was added to the in vitro assay. We have thus used several approaches to show a role for WRNp in RNA pol II transcription, possibly as a transcriptional activator. A deficit in either global or regional transcription in WS cells may be a primary molecular defect responsible for the WS clinical phenotype.</description><identifier>ISSN: 1059-1524</identifier><identifier>EISSN: 1939-4586</identifier><identifier>DOI: 10.1091/mbc.10.8.2655</identifier><identifier>PMID: 10436020</identifier><language>eng</language><publisher>United States: The American Society for Cell Biology</publisher><subject>Amino Acid Sequence ; Cell Extracts ; Cell Line ; Cell Membrane Permeability ; Cell Nucleus - metabolism ; Chromatin - genetics ; DNA Helicases - genetics ; DNA Helicases - isolation &amp; purification ; DNA Helicases - metabolism ; Exodeoxyribonucleases ; Fluorescent Antibody Technique ; Genetic Complementation Test ; Humans ; Molecular Sequence Data ; Mutation ; Plasmids - genetics ; RecQ Helicases ; Repetitive Sequences, Amino Acid ; RNA - biosynthesis ; RNA Polymerase II - genetics ; Transcription, Genetic ; Werner Syndrome - genetics ; Werner Syndrome - pathology ; Werner Syndrome Helicase</subject><ispartof>Molecular biology of the cell, 1999-08, Vol.10 (8), p.2655-2668</ispartof><rights>Copyright © 1999, The American Society for Cell Biology 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-88b43d4e14f7a09488853d256e9b3fc5cecb974bbdebdbec97b537d241588bbe3</citedby><cites>FETCH-LOGICAL-c478t-88b43d4e14f7a09488853d256e9b3fc5cecb974bbdebdbec97b537d241588bbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC25497/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC25497/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10436020$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Gall, Joseph</contributor><creatorcontrib>Balajee, A S</creatorcontrib><creatorcontrib>Machwe, A</creatorcontrib><creatorcontrib>May, A</creatorcontrib><creatorcontrib>Gray, M D</creatorcontrib><creatorcontrib>Oshima, J</creatorcontrib><creatorcontrib>Martin, G M</creatorcontrib><creatorcontrib>Nehlin, J O</creatorcontrib><creatorcontrib>Brosh, R</creatorcontrib><creatorcontrib>Orren, D K</creatorcontrib><creatorcontrib>Bohr, V A</creatorcontrib><title>The Werner syndrome protein is involved in RNA polymerase II transcription</title><title>Molecular biology of the cell</title><addtitle>Mol Biol Cell</addtitle><description>Werner syndrome (WS) is a human progeroid syndrome characterized by the early onset of a large number of clinical features associated with the normal aging process. The complex molecular and cellular phenotypes of WS involve characteristic features of genomic instability and accelerated replicative senescence. The gene involved (WRN) was recently cloned, and its gene product (WRNp) was biochemically characterized as a helicase. Helicases play important roles in a variety of DNA transactions, including DNA replication, transcription, repair, and recombination. We have assessed the role of the WRN gene in transcription by analyzing the efficiency of basal transcription in WS lymphoblastoid cell lines that carry homozygous WRN mutations. Transcription was measured in permeabilized cells by [3H]UTP incorporation and in vitro by using a plasmid template containing the RNA polymerase II (RNA pol II)-dependent adenovirus major late promoter. With both of these approaches, we find that the transcription efficiency in different WS cell lines is reduced to 40-60% of the transcription in cells from normal individuals. This defect can be complemented by the addition of normal cell extracts to the chromatin of WS cells. Addition of purified wild-type WRNp but not mutated WRNp to the in vitro transcription assay markedly stimulates RNA pol II-dependent transcription carried out by nuclear extracts. A nonhelicase domain (a direct repeat of 27 amino acids) also appears to have a role in transcription enhancement, as revealed by a yeast hybrid-protein reporter assay. This is further supported by the lack of stimulation of transcription when mutant WRNp lacking this domain was added to the in vitro assay. We have thus used several approaches to show a role for WRNp in RNA pol II transcription, possibly as a transcriptional activator. A deficit in either global or regional transcription in WS cells may be a primary molecular defect responsible for the WS clinical phenotype.</description><subject>Amino Acid Sequence</subject><subject>Cell Extracts</subject><subject>Cell Line</subject><subject>Cell Membrane Permeability</subject><subject>Cell Nucleus - metabolism</subject><subject>Chromatin - genetics</subject><subject>DNA Helicases - genetics</subject><subject>DNA Helicases - isolation &amp; purification</subject><subject>DNA Helicases - metabolism</subject><subject>Exodeoxyribonucleases</subject><subject>Fluorescent Antibody Technique</subject><subject>Genetic Complementation Test</subject><subject>Humans</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Plasmids - genetics</subject><subject>RecQ Helicases</subject><subject>Repetitive Sequences, Amino Acid</subject><subject>RNA - biosynthesis</subject><subject>RNA Polymerase II - genetics</subject><subject>Transcription, Genetic</subject><subject>Werner Syndrome - genetics</subject><subject>Werner Syndrome - pathology</subject><subject>Werner Syndrome Helicase</subject><issn>1059-1524</issn><issn>1939-4586</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM1LAzEQxYMoWqtHr5KTt63JbrKbgJciflSKglQ8hk12aiO7yZpsC_3vTamInubBvDfz-CF0QcmEEkmvO22SmIhJXnJ-gEZUFjJjXJSHSRMuM8pzdoJOY_wkhDJWVsfohBJWlCQnI_S0WAF-h-Ag4Lh1TfAd4D74AazDNmLrNr7dQJMEfn2e4t632w5CHQHPZngItYsm2H6w3p2ho2XdRjj_mWP0dn-3uH3M5i8Ps9vpPDOsEkMmhGZFw4CyZVUTyYQQvGhyXoLUxdJwA0bLimndgG40GFlpXlRNzihPUQ3FGN3s7_Zr3UFjwKUareqD7eqwVb626v_G2ZX68BuVcyarFL_6iQf_tYY4qM5GA21bO_DrqEqZCPKyTMZsbzTBxxhg-fuCErVjrxL7nRZqxz75L__2-uPewy6-AU64glA</recordid><startdate>19990801</startdate><enddate>19990801</enddate><creator>Balajee, A S</creator><creator>Machwe, A</creator><creator>May, A</creator><creator>Gray, M D</creator><creator>Oshima, J</creator><creator>Martin, G M</creator><creator>Nehlin, J O</creator><creator>Brosh, R</creator><creator>Orren, D K</creator><creator>Bohr, V A</creator><general>The American Society for Cell Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990801</creationdate><title>The Werner syndrome protein is involved in RNA polymerase II transcription</title><author>Balajee, A S ; Machwe, A ; May, A ; Gray, M D ; Oshima, J ; Martin, G M ; Nehlin, J O ; Brosh, R ; Orren, D K ; Bohr, V A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-88b43d4e14f7a09488853d256e9b3fc5cecb974bbdebdbec97b537d241588bbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Sequence</topic><topic>Cell Extracts</topic><topic>Cell Line</topic><topic>Cell Membrane Permeability</topic><topic>Cell Nucleus - metabolism</topic><topic>Chromatin - genetics</topic><topic>DNA Helicases - genetics</topic><topic>DNA Helicases - isolation &amp; purification</topic><topic>DNA Helicases - metabolism</topic><topic>Exodeoxyribonucleases</topic><topic>Fluorescent Antibody Technique</topic><topic>Genetic Complementation Test</topic><topic>Humans</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Plasmids - genetics</topic><topic>RecQ Helicases</topic><topic>Repetitive Sequences, Amino Acid</topic><topic>RNA - biosynthesis</topic><topic>RNA Polymerase II - genetics</topic><topic>Transcription, Genetic</topic><topic>Werner Syndrome - genetics</topic><topic>Werner Syndrome - pathology</topic><topic>Werner Syndrome Helicase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balajee, A S</creatorcontrib><creatorcontrib>Machwe, A</creatorcontrib><creatorcontrib>May, A</creatorcontrib><creatorcontrib>Gray, M D</creatorcontrib><creatorcontrib>Oshima, J</creatorcontrib><creatorcontrib>Martin, G M</creatorcontrib><creatorcontrib>Nehlin, J O</creatorcontrib><creatorcontrib>Brosh, R</creatorcontrib><creatorcontrib>Orren, D K</creatorcontrib><creatorcontrib>Bohr, V A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular biology of the cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balajee, A S</au><au>Machwe, A</au><au>May, A</au><au>Gray, M D</au><au>Oshima, J</au><au>Martin, G M</au><au>Nehlin, J O</au><au>Brosh, R</au><au>Orren, D K</au><au>Bohr, V A</au><au>Gall, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Werner syndrome protein is involved in RNA polymerase II transcription</atitle><jtitle>Molecular biology of the cell</jtitle><addtitle>Mol Biol Cell</addtitle><date>1999-08-01</date><risdate>1999</risdate><volume>10</volume><issue>8</issue><spage>2655</spage><epage>2668</epage><pages>2655-2668</pages><issn>1059-1524</issn><eissn>1939-4586</eissn><abstract>Werner syndrome (WS) is a human progeroid syndrome characterized by the early onset of a large number of clinical features associated with the normal aging process. The complex molecular and cellular phenotypes of WS involve characteristic features of genomic instability and accelerated replicative senescence. The gene involved (WRN) was recently cloned, and its gene product (WRNp) was biochemically characterized as a helicase. Helicases play important roles in a variety of DNA transactions, including DNA replication, transcription, repair, and recombination. We have assessed the role of the WRN gene in transcription by analyzing the efficiency of basal transcription in WS lymphoblastoid cell lines that carry homozygous WRN mutations. Transcription was measured in permeabilized cells by [3H]UTP incorporation and in vitro by using a plasmid template containing the RNA polymerase II (RNA pol II)-dependent adenovirus major late promoter. With both of these approaches, we find that the transcription efficiency in different WS cell lines is reduced to 40-60% of the transcription in cells from normal individuals. This defect can be complemented by the addition of normal cell extracts to the chromatin of WS cells. Addition of purified wild-type WRNp but not mutated WRNp to the in vitro transcription assay markedly stimulates RNA pol II-dependent transcription carried out by nuclear extracts. A nonhelicase domain (a direct repeat of 27 amino acids) also appears to have a role in transcription enhancement, as revealed by a yeast hybrid-protein reporter assay. This is further supported by the lack of stimulation of transcription when mutant WRNp lacking this domain was added to the in vitro assay. We have thus used several approaches to show a role for WRNp in RNA pol II transcription, possibly as a transcriptional activator. A deficit in either global or regional transcription in WS cells may be a primary molecular defect responsible for the WS clinical phenotype.</abstract><cop>United States</cop><pub>The American Society for Cell Biology</pub><pmid>10436020</pmid><doi>10.1091/mbc.10.8.2655</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1059-1524
ispartof Molecular biology of the cell, 1999-08, Vol.10 (8), p.2655-2668
issn 1059-1524
1939-4586
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_25497
source MEDLINE; PubMed Central; Free Full-Text Journals in Chemistry
subjects Amino Acid Sequence
Cell Extracts
Cell Line
Cell Membrane Permeability
Cell Nucleus - metabolism
Chromatin - genetics
DNA Helicases - genetics
DNA Helicases - isolation & purification
DNA Helicases - metabolism
Exodeoxyribonucleases
Fluorescent Antibody Technique
Genetic Complementation Test
Humans
Molecular Sequence Data
Mutation
Plasmids - genetics
RecQ Helicases
Repetitive Sequences, Amino Acid
RNA - biosynthesis
RNA Polymerase II - genetics
Transcription, Genetic
Werner Syndrome - genetics
Werner Syndrome - pathology
Werner Syndrome Helicase
title The Werner syndrome protein is involved in RNA polymerase II transcription
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A50%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Werner%20syndrome%20protein%20is%20involved%20in%20RNA%20polymerase%20II%20transcription&rft.jtitle=Molecular%20biology%20of%20the%20cell&rft.au=Balajee,%20A%20S&rft.date=1999-08-01&rft.volume=10&rft.issue=8&rft.spage=2655&rft.epage=2668&rft.pages=2655-2668&rft.issn=1059-1524&rft.eissn=1939-4586&rft_id=info:doi/10.1091/mbc.10.8.2655&rft_dat=%3Cproquest_pubme%3E69939566%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69939566&rft_id=info:pmid/10436020&rfr_iscdi=true